how prevalent/costly is FMS
~2-5% of population. Costs as much as OA
three conditions for diagnosis
widespread pain >=7 and symptom severity >=5; symptoms for at least 3 months; no other explanation
main FMS symptoms
systemic pain, fatigue, unrefreshing sleep
what are the three FDA approved drugs
milnacipran and duloxetine (SNRIs), pregabalin “lyrica” (GABA agonist)
dosing of lyrica
75 mg BID
dosing of duloxetine
60 mg QD (30 for first week)
first line of treatment
improve sleep and lifestyle factors